secwatch.observer — SEC 8-K summary
======================================

Issuer:     Spero Therapeutics, Inc. (SPRO)
CIK:        0001701108
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0001193125-24-003807
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Spero Therapeutics files updated investor presentation; no specific new material details provided
--------------------------------------------------------------------------------

- Company updated its corporate investor presentation on January 8, 2024.
- Presentation made available on company's website; content not summarized in the 8-K.
- No financial or operational updates disclosed in the filing body.
- Company disclaims obligation to update the presentation after this date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1701108/000119312524003807/0001193125-24-003807-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1701108/000119312524003807/d12871d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-003807

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer